Literature DB >> 24411019

Role of ERK1, 2, and 5 in dopamine neuron survival during aging.

Mayur S Parmar1, Juliann D Jaumotte2, Stephanie L Wyrostek2, Michael J Zigmond2, Jane E Cavanaugh3.   

Abstract

Extracellular signal-regulated kinases (ERKs) 1, 2, and 5 have been shown to play distinct roles in proliferation, differentiation, and neuronal viability. In this study, we examined ERK1, 2, and 5 expression and activation in the substantia nigra (SN), striatum (STR), and ventral tegmental area (VTA) during aging. An age-related decrease in phosphorylated ERK5 was observed in the SN and STR, whereas an increase in total ERK1 was observed in all 3 regions. In primary cultures of the SN and VTA, inhibition of ERK5 but not ERK1 and 2 decreased dopamine neuronal viability significantly. These data suggest that ERK5 is essential for the basal survival of SN and VTA dopaminergic neurons. This is the first study to examine ERK1, 2, and 5 expression and activation in the SN, STR, and VTA during aging, and the relative roles of ERK1, 2, and 5 in basal survival of SN and VTA dopaminergic neurons. These data raise the possibility that a decline in ERK5 signaling may play a role in age-related impairments in dopaminergic function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Brain; ERK1/2; ERK5; Fischer-344xBrown Norway F1 hybrids (F344xBN F1); MAP kinases; Striatum; Substantia nigra; Ventral tegmental area

Mesh:

Substances:

Year:  2013        PMID: 24411019      PMCID: PMC3896870          DOI: 10.1016/j.neurobiolaging.2013.09.031

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

1.  Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.

Authors:  C M Fox; D M Gash; M K Smoot; W A Cass
Journal:  Brain Res       Date:  2001-03-30       Impact factor: 3.252

2.  Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.

Authors:  Y Hayashi; T Iwashita; H Murakamai; Y Kato; K Kawai; K Kurokawa; I Tohnai; M Ueda; M Takahashi
Journal:  Biochem Biophys Res Commun       Date:  2001-03-02       Impact factor: 3.575

3.  Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway.

Authors:  N Mody; J Leitch; C Armstrong; J Dixon; P Cohen
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

4.  Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.

Authors:  J E Cavanaugh; J Ham; M Hetman; S Poser; C Yan; Z Xia
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

5.  A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra.

Authors:  H A Boger; L D Middaugh; P Huang; V Zaman; A C Smith; B J Hoffer; A C Tomac; A-Ch Granholm
Journal:  Exp Neurol       Date:  2006-08-02       Impact factor: 5.330

6.  Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.

Authors:  Azucena Esparís-Ogando; Elena Díaz-Rodríguez; Juan Carlos Montero; Laura Yuste; Piero Crespo; Atanasio Pandiella
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Neurotrophins use the Erk5 pathway to mediate a retrograde survival response.

Authors:  F L Watson; H M Heerssen; A Bhattacharyya; L Klesse; M Z Lin; R A Segal
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

Review 8.  Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

Authors:  G J Siegel; N B Chauhan
Journal:  Brain Res Brain Res Rev       Date:  2000-09

9.  Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern.

Authors:  Aryaman Shalizi; Maria Lehtinen; Brice Gaudilliere; Nicole Donovan; Jiahuai Han; Yoshiyuki Konishi; Azad Bonni
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

10.  ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons.

Authors:  Lidong Liu; Jane E Cavanaugh; Yupeng Wang; Hiroyuki Sakagami; Zixu Mao; Zhengui Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 11.205

View more
  10 in total

1.  Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.

Authors:  Erika N Allen; Sneha Potdar; Victor Tapias; Mayur Parmar; Cassia S Mizuno; Agnes Rimando; Jane E Cavanaugh
Journal:  J Nutr Biochem       Date:  2017-11-04       Impact factor: 6.048

2.  Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model.

Authors:  Onat Akyol; Prativa Sherchan; Gokce Yilmaz; Cesar Reis; Wingi Man Ho; Yuechun Wang; Lei Huang; Ihsan Solaroglu; John H Zhang
Journal:  Exp Neurol       Date:  2018-06-05       Impact factor: 5.330

3.  Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats.

Authors:  Elena Pinceti; Cody L Shults; Yathindar S Rao; Toni R Pak
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

4.  Yeast genetic interaction screen of human genes associated with amyotrophic lateral sclerosis: identification of MAP2K5 kinase as a potential drug target.

Authors:  Myungjin Jo; Ah Young Chung; Nozomu Yachie; Minchul Seo; Hyejin Jeon; Youngpyo Nam; Yeojin Seo; Eunmi Kim; Quan Zhong; Marc Vidal; Hae Chul Park; Frederick P Roth; Kyoungho Suk
Journal:  Genome Res       Date:  2017-06-08       Impact factor: 9.043

5.  Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic.

Authors:  Natosha M Mercado; Timothy J Collier; Thomas Freeman; Kathy Steece-Collier
Journal:  J Clin Cell Immunol       Date:  2016-12-06

6.  Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.

Authors:  Claudia Fuchs; Laura Gennaccaro; Stefania Trazzi; Stefano Bastianini; Simone Bettini; Viviana Lo Martire; Elisa Ren; Giorgio Medici; Giovanna Zoccoli; Roberto Rimondini; Elisabetta Ciani
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

Review 7.  Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.

Authors:  Reka P Toth; Julie D Atkin
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 8.  Modulation of neurotrophic signaling pathways by polyphenols.

Authors:  Fatemeh Moosavi; Razieh Hosseini; Luciano Saso; Omidreza Firuzi
Journal:  Drug Des Devel Ther       Date:  2015-12-21       Impact factor: 4.162

Review 9.  Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?

Authors:  Kelsey E Murphy; Joshua J Park
Journal:  Int J Mol Sci       Date:  2017-05-31       Impact factor: 5.923

10.  Gender- and region-specific changes in estrogen signaling in aging rat brain mitochondria.

Authors:  Christopher M Evola; Tanner L Hudson; Luping Huang; Adrian M Corbett; Debra A Mayes
Journal:  Aging (Albany NY)       Date:  2018-08-31       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.